Pharma & Healthcare
Global Non-injectable GnRH Drugs Market Research Report 2026
- Feb 24, 26
- ID: 720099
- Pages: 108
- Figures: 114
- Views: 1
This report delivers a comprehensive overview of the global Non-injectable GnRH Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Non-injectable GnRH Drugs. The Non-injectable GnRH Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Non-injectable GnRH Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Non-injectable GnRH Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi
Pfizer
Fuji Pharma
Neon Healthcare
Abbvie
ASKA Pharmaceutical
Sumitomo Pharma
ObsEva
JW Pharmaceutical
Segment by Type
Tablets
Nasal Spray
Others
by Application
Endometriosis
Uterine Fibroids
Menorrhagia
Central Precocious Puberty
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Non-injectable GnRH Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Non-injectable GnRH Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Non-injectable GnRH Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Non-injectable GnRH Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi
Pfizer
Fuji Pharma
Neon Healthcare
Abbvie
ASKA Pharmaceutical
Sumitomo Pharma
ObsEva
JW Pharmaceutical
Segment by Type
Tablets
Nasal Spray
Others
by Application
Endometriosis
Uterine Fibroids
Menorrhagia
Central Precocious Puberty
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Non-injectable GnRH Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Non-injectable GnRH Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Non-injectable GnRH Drugs Market Overview
1.1 Product Definition
1.2 Non-injectable GnRH Drugs by Type
1.2.1 Global Non-injectable GnRH Drugs Market Value by Type: 2025 vs 2032
1.2.2 Tablets
1.2.3 Nasal Spray
1.2.4 Others
1.3 Non-injectable GnRH Drugs by Application
1.3.1 Global Non-injectable GnRH Drugs Market Value by Application: 2025 vs 2032
1.3.2 Endometriosis
1.3.3 Uterine Fibroids
1.3.4 Menorrhagia
1.3.5 Central Precocious Puberty
1.3.6 Other
1.4 Global Non-injectable GnRH Drugs Market Size Estimates and Forecasts
1.4.1 Global Non-injectable GnRH Drugs Revenue 2021–2032
1.4.2 Global Non-injectable GnRH Drugs Sales 2021–2032
1.4.3 Global Non-injectable GnRH Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Non-injectable GnRH Drugs Market Competition by Manufacturers
2.1 Global Non-injectable GnRH Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Non-injectable GnRH Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Non-injectable GnRH Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Non-injectable GnRH Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Non-injectable GnRH Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Non-injectable GnRH Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Non-injectable GnRH Drugs, Date of Entry into the Industry
2.8 Global Non-injectable GnRH Drugs Market Competitive Situation and Trends
2.8.1 Global Non-injectable GnRH Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Non-injectable GnRH Drugs Players Market Share by Revenue
2.8.3 Global Non-injectable GnRH Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-injectable GnRH Drugs Market Scenario by Region
3.1 Global Non-injectable GnRH Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Non-injectable GnRH Drugs Sales by Region: 2021–2032
3.2.1 Global Non-injectable GnRH Drugs Sales by Region: 2021–2026
3.2.2 Global Non-injectable GnRH Drugs Sales by Region: 2027–2032
3.3 Global Non-injectable GnRH Drugs Revenue by Region: 2021–2032
3.3.1 Global Non-injectable GnRH Drugs Revenue by Region: 2021–2026
3.3.2 Global Non-injectable GnRH Drugs Revenue by Region: 2027–2032
3.4 North America Non-injectable GnRH Drugs Market Facts & Figures by Country
3.4.1 North America Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.4.3 North America Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-injectable GnRH Drugs Market Facts & Figures by Country
3.5.1 Europe Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.5.3 Europe Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-injectable GnRH Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Non-injectable GnRH Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Non-injectable GnRH Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Non-injectable GnRH Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-injectable GnRH Drugs Market Facts & Figures by Country
3.7.1 Latin America Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.7.3 Latin America Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-injectable GnRH Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-injectable GnRH Drugs Sales by Type (2021–2032)
4.1.1 Global Non-injectable GnRH Drugs Sales by Type (2021–2026)
4.1.2 Global Non-injectable GnRH Drugs Sales by Type (2027–2032)
4.1.3 Global Non-injectable GnRH Drugs Sales Market Share by Type (2021–2032)
4.2 Global Non-injectable GnRH Drugs Revenue by Type (2021–2032)
4.2.1 Global Non-injectable GnRH Drugs Revenue by Type (2021–2026)
4.2.2 Global Non-injectable GnRH Drugs Revenue by Type (2027–2032)
4.2.3 Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Non-injectable GnRH Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Non-injectable GnRH Drugs Sales by Application (2021–2032)
5.1.1 Global Non-injectable GnRH Drugs Sales by Application (2021–2026)
5.1.2 Global Non-injectable GnRH Drugs Sales by Application (2027–2032)
5.1.3 Global Non-injectable GnRH Drugs Sales Market Share by Application (2021–2032)
5.2 Global Non-injectable GnRH Drugs Revenue by Application (2021–2032)
5.2.1 Global Non-injectable GnRH Drugs Revenue by Application (2021–2026)
5.2.2 Global Non-injectable GnRH Drugs Revenue by Application (2027–2032)
5.2.3 Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Non-injectable GnRH Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Non-injectable GnRH Drugs Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Non-injectable GnRH Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Fuji Pharma
6.3.1 Fuji Pharma Company Information
6.3.2 Fuji Pharma Description and Business Overview
6.3.3 Fuji Pharma Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fuji Pharma Non-injectable GnRH Drugs Product Portfolio
6.3.5 Fuji Pharma Recent Developments/Updates
6.4 Neon Healthcare
6.4.1 Neon Healthcare Company Information
6.4.2 Neon Healthcare Description and Business Overview
6.4.3 Neon Healthcare Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Neon Healthcare Non-injectable GnRH Drugs Product Portfolio
6.4.5 Neon Healthcare Recent Developments/Updates
6.5 Abbvie
6.5.1 Abbvie Company Information
6.5.2 Abbvie Description and Business Overview
6.5.3 Abbvie Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Abbvie Non-injectable GnRH Drugs Product Portfolio
6.5.5 Abbvie Recent Developments/Updates
6.6 ASKA Pharmaceutical
6.6.1 ASKA Pharmaceutical Company Information
6.6.2 ASKA Pharmaceutical Description and Business Overview
6.6.3 ASKA Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
6.6.5 ASKA Pharmaceutical Recent Developments/Updates
6.7 Sumitomo Pharma
6.7.1 Sumitomo Pharma Company Information
6.7.2 Sumitomo Pharma Description and Business Overview
6.7.3 Sumitomo Pharma Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio
6.7.5 Sumitomo Pharma Recent Developments/Updates
6.8 ObsEva
6.8.1 ObsEva Company Information
6.8.2 ObsEva Description and Business Overview
6.8.3 ObsEva Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ObsEva Non-injectable GnRH Drugs Product Portfolio
6.8.5 ObsEva Recent Developments/Updates
6.9 JW Pharmaceutical
6.9.1 JW Pharmaceutical Company Information
6.9.2 JW Pharmaceutical Description and Business Overview
6.9.3 JW Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
6.9.5 JW Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-injectable GnRH Drugs Industry Chain Analysis
7.2 Non-injectable GnRH Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-injectable GnRH Drugs Production Mode & Process Analysis
7.4 Non-injectable GnRH Drugs Sales and Marketing
7.4.1 Non-injectable GnRH Drugs Sales Channels
7.4.2 Non-injectable GnRH Drugs Distributors
7.5 Non-injectable GnRH Drugs Customer Analysis
8 Non-injectable GnRH Drugs Market Dynamics
8.1 Non-injectable GnRH Drugs Industry Trends
8.2 Non-injectable GnRH Drugs Market Drivers
8.3 Non-injectable GnRH Drugs Market Challenges
8.4 Non-injectable GnRH Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Non-injectable GnRH Drugs by Type
1.2.1 Global Non-injectable GnRH Drugs Market Value by Type: 2025 vs 2032
1.2.2 Tablets
1.2.3 Nasal Spray
1.2.4 Others
1.3 Non-injectable GnRH Drugs by Application
1.3.1 Global Non-injectable GnRH Drugs Market Value by Application: 2025 vs 2032
1.3.2 Endometriosis
1.3.3 Uterine Fibroids
1.3.4 Menorrhagia
1.3.5 Central Precocious Puberty
1.3.6 Other
1.4 Global Non-injectable GnRH Drugs Market Size Estimates and Forecasts
1.4.1 Global Non-injectable GnRH Drugs Revenue 2021–2032
1.4.2 Global Non-injectable GnRH Drugs Sales 2021–2032
1.4.3 Global Non-injectable GnRH Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Non-injectable GnRH Drugs Market Competition by Manufacturers
2.1 Global Non-injectable GnRH Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Non-injectable GnRH Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Non-injectable GnRH Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Non-injectable GnRH Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Non-injectable GnRH Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Non-injectable GnRH Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Non-injectable GnRH Drugs, Date of Entry into the Industry
2.8 Global Non-injectable GnRH Drugs Market Competitive Situation and Trends
2.8.1 Global Non-injectable GnRH Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Non-injectable GnRH Drugs Players Market Share by Revenue
2.8.3 Global Non-injectable GnRH Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-injectable GnRH Drugs Market Scenario by Region
3.1 Global Non-injectable GnRH Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Non-injectable GnRH Drugs Sales by Region: 2021–2032
3.2.1 Global Non-injectable GnRH Drugs Sales by Region: 2021–2026
3.2.2 Global Non-injectable GnRH Drugs Sales by Region: 2027–2032
3.3 Global Non-injectable GnRH Drugs Revenue by Region: 2021–2032
3.3.1 Global Non-injectable GnRH Drugs Revenue by Region: 2021–2026
3.3.2 Global Non-injectable GnRH Drugs Revenue by Region: 2027–2032
3.4 North America Non-injectable GnRH Drugs Market Facts & Figures by Country
3.4.1 North America Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.4.3 North America Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-injectable GnRH Drugs Market Facts & Figures by Country
3.5.1 Europe Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.5.3 Europe Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-injectable GnRH Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Non-injectable GnRH Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Non-injectable GnRH Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Non-injectable GnRH Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-injectable GnRH Drugs Market Facts & Figures by Country
3.7.1 Latin America Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.7.3 Latin America Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-injectable GnRH Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-injectable GnRH Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-injectable GnRH Drugs Sales by Type (2021–2032)
4.1.1 Global Non-injectable GnRH Drugs Sales by Type (2021–2026)
4.1.2 Global Non-injectable GnRH Drugs Sales by Type (2027–2032)
4.1.3 Global Non-injectable GnRH Drugs Sales Market Share by Type (2021–2032)
4.2 Global Non-injectable GnRH Drugs Revenue by Type (2021–2032)
4.2.1 Global Non-injectable GnRH Drugs Revenue by Type (2021–2026)
4.2.2 Global Non-injectable GnRH Drugs Revenue by Type (2027–2032)
4.2.3 Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Non-injectable GnRH Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Non-injectable GnRH Drugs Sales by Application (2021–2032)
5.1.1 Global Non-injectable GnRH Drugs Sales by Application (2021–2026)
5.1.2 Global Non-injectable GnRH Drugs Sales by Application (2027–2032)
5.1.3 Global Non-injectable GnRH Drugs Sales Market Share by Application (2021–2032)
5.2 Global Non-injectable GnRH Drugs Revenue by Application (2021–2032)
5.2.1 Global Non-injectable GnRH Drugs Revenue by Application (2021–2026)
5.2.2 Global Non-injectable GnRH Drugs Revenue by Application (2027–2032)
5.2.3 Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Non-injectable GnRH Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Non-injectable GnRH Drugs Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Non-injectable GnRH Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Fuji Pharma
6.3.1 Fuji Pharma Company Information
6.3.2 Fuji Pharma Description and Business Overview
6.3.3 Fuji Pharma Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fuji Pharma Non-injectable GnRH Drugs Product Portfolio
6.3.5 Fuji Pharma Recent Developments/Updates
6.4 Neon Healthcare
6.4.1 Neon Healthcare Company Information
6.4.2 Neon Healthcare Description and Business Overview
6.4.3 Neon Healthcare Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Neon Healthcare Non-injectable GnRH Drugs Product Portfolio
6.4.5 Neon Healthcare Recent Developments/Updates
6.5 Abbvie
6.5.1 Abbvie Company Information
6.5.2 Abbvie Description and Business Overview
6.5.3 Abbvie Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Abbvie Non-injectable GnRH Drugs Product Portfolio
6.5.5 Abbvie Recent Developments/Updates
6.6 ASKA Pharmaceutical
6.6.1 ASKA Pharmaceutical Company Information
6.6.2 ASKA Pharmaceutical Description and Business Overview
6.6.3 ASKA Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
6.6.5 ASKA Pharmaceutical Recent Developments/Updates
6.7 Sumitomo Pharma
6.7.1 Sumitomo Pharma Company Information
6.7.2 Sumitomo Pharma Description and Business Overview
6.7.3 Sumitomo Pharma Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio
6.7.5 Sumitomo Pharma Recent Developments/Updates
6.8 ObsEva
6.8.1 ObsEva Company Information
6.8.2 ObsEva Description and Business Overview
6.8.3 ObsEva Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ObsEva Non-injectable GnRH Drugs Product Portfolio
6.8.5 ObsEva Recent Developments/Updates
6.9 JW Pharmaceutical
6.9.1 JW Pharmaceutical Company Information
6.9.2 JW Pharmaceutical Description and Business Overview
6.9.3 JW Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
6.9.5 JW Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-injectable GnRH Drugs Industry Chain Analysis
7.2 Non-injectable GnRH Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-injectable GnRH Drugs Production Mode & Process Analysis
7.4 Non-injectable GnRH Drugs Sales and Marketing
7.4.1 Non-injectable GnRH Drugs Sales Channels
7.4.2 Non-injectable GnRH Drugs Distributors
7.5 Non-injectable GnRH Drugs Customer Analysis
8 Non-injectable GnRH Drugs Market Dynamics
8.1 Non-injectable GnRH Drugs Industry Trends
8.2 Non-injectable GnRH Drugs Market Drivers
8.3 Non-injectable GnRH Drugs Market Challenges
8.4 Non-injectable GnRH Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Non-injectable GnRH Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Non-injectable GnRH Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Non-injectable GnRH Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Non-injectable GnRH Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Non-injectable GnRH Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Non-injectable GnRH Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Non-injectable GnRH Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Non-injectable GnRH Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Non-injectable GnRH Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Non-injectable GnRH Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Non-injectable GnRH Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-injectable GnRH Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Non-injectable GnRH Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-injectable GnRH Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Non-injectable GnRH Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Non-injectable GnRH Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Non-injectable GnRH Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Non-injectable GnRH Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Non-injectable GnRH Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Non-injectable GnRH Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Non-injectable GnRH Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Non-injectable GnRH Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Non-injectable GnRH Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Non-injectable GnRH Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Non-injectable GnRH Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Non-injectable GnRH Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Non-injectable GnRH Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Non-injectable GnRH Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Non-injectable GnRH Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Non-injectable GnRH Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Non-injectable GnRH Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Non-injectable GnRH Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Non-injectable GnRH Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Non-injectable GnRH Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Non-injectable GnRH Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi Non-injectable GnRH Drugs Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Non-injectable GnRH Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Fuji Pharma Company Information
Table 81. Fuji Pharma Description and Business Overview
Table 82. Fuji Pharma Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Fuji Pharma Non-injectable GnRH Drugs Product
Table 84. Fuji Pharma Recent Developments/Updates
Table 85. Neon Healthcare Company Information
Table 86. Neon Healthcare Description and Business Overview
Table 87. Neon Healthcare Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Neon Healthcare Non-injectable GnRH Drugs Product
Table 89. Neon Healthcare Recent Developments/Updates
Table 90. Abbvie Company Information
Table 91. Abbvie Description and Business Overview
Table 92. Abbvie Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Abbvie Non-injectable GnRH Drugs Product
Table 94. Abbvie Recent Developments/Updates
Table 95. ASKA Pharmaceutical Company Information
Table 96. ASKA Pharmaceutical Description and Business Overview
Table 97. ASKA Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. ASKA Pharmaceutical Non-injectable GnRH Drugs Product
Table 99. ASKA Pharmaceutical Recent Developments/Updates
Table 100. Sumitomo Pharma Company Information
Table 101. Sumitomo Pharma Description and Business Overview
Table 102. Sumitomo Pharma Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sumitomo Pharma Non-injectable GnRH Drugs Product
Table 104. Sumitomo Pharma Recent Developments/Updates
Table 105. ObsEva Company Information
Table 106. ObsEva Description and Business Overview
Table 107. ObsEva Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. ObsEva Non-injectable GnRH Drugs Product
Table 109. ObsEva Recent Developments/Updates
Table 110. JW Pharmaceutical Company Information
Table 111. JW Pharmaceutical Description and Business Overview
Table 112. JW Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. JW Pharmaceutical Non-injectable GnRH Drugs Product
Table 114. JW Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Non-injectable GnRH Drugs Distributors List
Table 118. Non-injectable GnRH Drugs Customers List
Table 119. Non-injectable GnRH Drugs Market Trends
Table 120. Non-injectable GnRH Drugs Market Drivers
Table 121. Non-injectable GnRH Drugs Market Challenges
Table 122. Non-injectable GnRH Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-injectable GnRH Drugs
Figure 2. Global Non-injectable GnRH Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Non-injectable GnRH Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Nasal Spray Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-injectable GnRH Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Non-injectable GnRH Drugs Market Share by Application: 2025 & 2032
Figure 9. Endometriosis
Figure 10. Uterine Fibroids
Figure 11. Menorrhagia
Figure 12. Central Precocious Puberty
Figure 13. Other
Figure 14. Global Non-injectable GnRH Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Non-injectable GnRH Drugs Market Size (US$ Million), 2021–2032
Figure 16. Global Non-injectable GnRH Drugs Sales (K Units), 2021–2032
Figure 17. Global Non-injectable GnRH Drugs Average Price (US$/Unit), 2021–2032
Figure 18. Non-injectable GnRH Drugs Report Years Considered
Figure 19. Non-injectable GnRH Drugs Sales Share by Manufacturers in 2025
Figure 20. Global Non-injectable GnRH Drugs Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Non-injectable GnRH Drugs Players: Market Share by Revenue in Non-injectable GnRH Drugs in 2025
Figure 22. Non-injectable GnRH Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Non-injectable GnRH Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 25. North America Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 26. United States Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 29. Europe Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 30. Germany Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Non-injectable GnRH Drugs Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Non-injectable GnRH Drugs Revenue Market Share by Region (2021–2032)
Figure 37. China Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 45. Latin America Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Non-injectable GnRH Drugs by Type (2021–2032)
Figure 56. Global Revenue Market Share of Non-injectable GnRH Drugs by Type (2021–2032)
Figure 57. Global Non-injectable GnRH Drugs Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Non-injectable GnRH Drugs by Application (2021–2032)
Figure 59. Global Revenue Market Share of Non-injectable GnRH Drugs by Application (2021–2032)
Figure 60. Global Non-injectable GnRH Drugs Price (US$/Unit) by Application (2021–2032)
Figure 61. Non-injectable GnRH Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Non-injectable GnRH Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Non-injectable GnRH Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Non-injectable GnRH Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Non-injectable GnRH Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Non-injectable GnRH Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Non-injectable GnRH Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Non-injectable GnRH Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Non-injectable GnRH Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Non-injectable GnRH Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Non-injectable GnRH Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Non-injectable GnRH Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-injectable GnRH Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Non-injectable GnRH Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-injectable GnRH Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Non-injectable GnRH Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Non-injectable GnRH Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Non-injectable GnRH Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Non-injectable GnRH Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Non-injectable GnRH Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Non-injectable GnRH Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Non-injectable GnRH Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Non-injectable GnRH Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Non-injectable GnRH Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Non-injectable GnRH Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Non-injectable GnRH Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Non-injectable GnRH Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Non-injectable GnRH Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Non-injectable GnRH Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Non-injectable GnRH Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Non-injectable GnRH Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Non-injectable GnRH Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Non-injectable GnRH Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Non-injectable GnRH Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Non-injectable GnRH Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Non-injectable GnRH Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Non-injectable GnRH Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Non-injectable GnRH Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Non-injectable GnRH Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Non-injectable GnRH Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Non-injectable GnRH Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Non-injectable GnRH Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi Non-injectable GnRH Drugs Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Non-injectable GnRH Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Fuji Pharma Company Information
Table 81. Fuji Pharma Description and Business Overview
Table 82. Fuji Pharma Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Fuji Pharma Non-injectable GnRH Drugs Product
Table 84. Fuji Pharma Recent Developments/Updates
Table 85. Neon Healthcare Company Information
Table 86. Neon Healthcare Description and Business Overview
Table 87. Neon Healthcare Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Neon Healthcare Non-injectable GnRH Drugs Product
Table 89. Neon Healthcare Recent Developments/Updates
Table 90. Abbvie Company Information
Table 91. Abbvie Description and Business Overview
Table 92. Abbvie Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Abbvie Non-injectable GnRH Drugs Product
Table 94. Abbvie Recent Developments/Updates
Table 95. ASKA Pharmaceutical Company Information
Table 96. ASKA Pharmaceutical Description and Business Overview
Table 97. ASKA Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. ASKA Pharmaceutical Non-injectable GnRH Drugs Product
Table 99. ASKA Pharmaceutical Recent Developments/Updates
Table 100. Sumitomo Pharma Company Information
Table 101. Sumitomo Pharma Description and Business Overview
Table 102. Sumitomo Pharma Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sumitomo Pharma Non-injectable GnRH Drugs Product
Table 104. Sumitomo Pharma Recent Developments/Updates
Table 105. ObsEva Company Information
Table 106. ObsEva Description and Business Overview
Table 107. ObsEva Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. ObsEva Non-injectable GnRH Drugs Product
Table 109. ObsEva Recent Developments/Updates
Table 110. JW Pharmaceutical Company Information
Table 111. JW Pharmaceutical Description and Business Overview
Table 112. JW Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. JW Pharmaceutical Non-injectable GnRH Drugs Product
Table 114. JW Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Non-injectable GnRH Drugs Distributors List
Table 118. Non-injectable GnRH Drugs Customers List
Table 119. Non-injectable GnRH Drugs Market Trends
Table 120. Non-injectable GnRH Drugs Market Drivers
Table 121. Non-injectable GnRH Drugs Market Challenges
Table 122. Non-injectable GnRH Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-injectable GnRH Drugs
Figure 2. Global Non-injectable GnRH Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Non-injectable GnRH Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Nasal Spray Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-injectable GnRH Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Non-injectable GnRH Drugs Market Share by Application: 2025 & 2032
Figure 9. Endometriosis
Figure 10. Uterine Fibroids
Figure 11. Menorrhagia
Figure 12. Central Precocious Puberty
Figure 13. Other
Figure 14. Global Non-injectable GnRH Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Non-injectable GnRH Drugs Market Size (US$ Million), 2021–2032
Figure 16. Global Non-injectable GnRH Drugs Sales (K Units), 2021–2032
Figure 17. Global Non-injectable GnRH Drugs Average Price (US$/Unit), 2021–2032
Figure 18. Non-injectable GnRH Drugs Report Years Considered
Figure 19. Non-injectable GnRH Drugs Sales Share by Manufacturers in 2025
Figure 20. Global Non-injectable GnRH Drugs Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Non-injectable GnRH Drugs Players: Market Share by Revenue in Non-injectable GnRH Drugs in 2025
Figure 22. Non-injectable GnRH Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Non-injectable GnRH Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 25. North America Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 26. United States Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 29. Europe Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 30. Germany Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Non-injectable GnRH Drugs Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Non-injectable GnRH Drugs Revenue Market Share by Region (2021–2032)
Figure 37. China Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 45. Latin America Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Non-injectable GnRH Drugs Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Non-injectable GnRH Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Non-injectable GnRH Drugs by Type (2021–2032)
Figure 56. Global Revenue Market Share of Non-injectable GnRH Drugs by Type (2021–2032)
Figure 57. Global Non-injectable GnRH Drugs Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Non-injectable GnRH Drugs by Application (2021–2032)
Figure 59. Global Revenue Market Share of Non-injectable GnRH Drugs by Application (2021–2032)
Figure 60. Global Non-injectable GnRH Drugs Price (US$/Unit) by Application (2021–2032)
Figure 61. Non-injectable GnRH Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232